Top Pharmaceuticals stocks in Europe
Manufacturers and marketers of generic and specialty drugs, as well as researchers and developers of new drugs, medical products and procedures.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
NOVO BNovo Nordisk A/S | DKK3.91tn | 46.67 | 1.06% |
AZNAstraZeneca | £185.83bn | 47.97 | 1.93% |
ROGRoche Holding AG | CH₣176.19bn | 12.28 | 4.34% |
RORoche Holding AG | CH₣176.19bn | 13.34 | 4% |
NOVNNovartis AG | CH₣175.11bn | 17.14 | 4% |
SANSanofi SA | €114.16bn | 17.27 | 4.12% |
GSKGSK | £68.51bn | 11.78 | 3.51% |
MRKMerck KGaA | €65.98bn | 19.78 | 1.45% |
HLNHALEON | £30.54bn | 23.32 | 1.79% |
BAYNBayer AG | €26.92bn | 4.28 | 0.4% |
UCBUCB SA | €23.63bn | 89.05 | 0.76% |
SDZSandoz AG | CH₣12.90bn | 11.66 | 1.63% |
RECRecordati Industria Chimica E Farmaceutica SpA | €10.11bn | 28.54 | 2.44% |
IPNIpsen SA | €9.34bn | 21.49 | 1.06% |
SOBISwedish Orphan Biovitrum AB (publ) | SEK95.50bn | 36.03 | n/a |
GRFGrifols SA | €5.69bn | 16.29 | n/a |
DPHDechra Pharmaceuticals | £4.40bn | 67.15 | n/a |
CLS1McKesson Europe AG | €4.96bn | n/a | n/a |
ORNBVOrion Oyj | €5.04bn | 23.17 | 4.52% |
HIKHikma Pharmaceuticals | £4.24bn | 10.82 | 3.03% |